Leonardo was a "digital pathology collaboration network – fully integrated in its pathology process and workflow system DaVinci" that "enables pathologists to share cases and their related digital slides and images with colleagues worldwide." Sometime in 2021, the Leonardo application was removed from the company website, and it is presumed either discontinued or integrated into DaVinci. On September 16, 2022, the company changed its legal name to Clinisys NV, as part of a universal rebranding associated with various other prior acquisitions by Clinisys. On April 30, 2021, MIPS announced its new GLIMS Genetics, described as combining "the power of a mature laboratory information system (LIS) for ‘traditional’ specialties with the specific needs of genetics, including those linked to more recent technologies such as next-generation sequencing (NGS)." On January 7, 2016, Montagu Private Equity LLP announced the completion of the sale of CliniSys to Roper Technologies CliniSys made a similar announcement on the 26. The press release noted, however, that "ompletion of the CliniSys acquisition is dependent upon receiving approval from the competition authorities in Germany and the United Kingdom," and that "ollaboration between Sunquest and CliniSys will not begin until formal approval is received." announced that its parent company Roper Technologies had acquired both CliniSys Group Limited and Atlas Medical. On October 26, 2015, Sunquest Information Systems, Inc. In February 2015, MIPS acquired MCS-LDS, the Germany-based laboratory information systems business unit of MCS AG, know for their products Vianova Labor and PROMED Open/X-PROMED. The company planned to assist abandoned GesLab users and help them transition to GLIMS, MIPS' LIS offering. In February 2011, MIPS acquired the property of Gespower SA-including its LIS GesLab-after it went bankrupt. In July 2005, CliniSys Group Limited acquired MIPS NV. MIPS NV was founded in Flanders, Belgium in 1985. 2.1.3 Demonstration videos and other media.2.1 Clinisys GLIMS, DaVinci, and CyberLab.We believe now is the time for them to benefit from all the advantages that a bespoke modern LIMS can provide, and GLIMS Genomics will enable them to do that through its fully customisable features, workflows and interfaces. “They need to move away from the labour-intensive, disjointed spreadsheet or paper-based management of samples, to a more automated, streamlined approach so they can increase their sample throughput, adopt standardised workflows, and seamlessly deliver results to clinicians via integration with the electronic patient record. It is on the cusp of being an established diagnostic tool for some cohorts of patients. To support this development, genomic laboratories need to change and the technology they use will need to change with them. These aim to deliver a comprehensive, standardised testing service for English hospitals, as genomic testing starts to become a routine part of clinical practice.Įmma Huntridge at CliniSys, said: “Genomic medicine is no longer the preserve of a few, small, research groups. GLIMS Genomics has been designed to support the effective management of genomic laboratories and the UK launch is particularly timely as the NHS is now delivering a national Genomic Medicine Service for England through seven Genomic Laboratory Hubs. The company has brought GLIMS Genomics to the UK from Europe, where it is being successfully deployed at Poitiers University Hospital in France and will be introduced into seven additional laboratories in coming months. CliniSys has launched a new laboratory information management system (LIMS) for genomic laboratories in the UK.
0 kommentar(er)
